Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00143858 · ClinicalTrials.gov registry record
Assessment of the Clinical Utility of Non Invasive Peripheral Signal Averaged Pulse Volume
A clinical trial, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- 16
- Enrollment target
NCT00143858: Completed study, sponsored by University of Medicine and Dentistry of New Jersey.
NCT00143858 is a clinical trial that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00143858 has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the clinical usefulness of measuring the heart's pumping ability by measuring the Peripheral Pulse Volume (PPV).
Interventions
- DEVICE Pulse Volume Measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2004-09 |
| Est. Completion | 2007-10 |
What the finished NCT00143858 record still lists
NCT00143858 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pulse Volume Measurement is the first listed.
NCT00143858 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00143858 about?
NCT00143858 is a clinical study titled "Assessment of the Clinical Utility of Non Invasive Peripheral Signal Averaged Pulse Volume". The purpose of this study is to determine the clinical usefulness of measuring the heart's pumping ability by measuring the Peripheral Pulse Volume (PPV).
What is the current status of trial NCT00143858?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2004-09. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00143858?
The interventions under investigation include: Pulse Volume Measurement (DEVICE).
Who is sponsoring clinical trial NCT00143858?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia